Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PGD2 receptor antagonists for the treatment of inflammatory diseases

PGD2 receptor antagonists for the treatment of inflammatory diseases

US Patent 7211672 · Granted May 1, 2007

Estimated economic value: $10,564,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for treating conditions associated with NLRP activity2025
NLRP3 modulators2025
Potent ASGPR-binding compounds for the degradation of immunoglobulins and other 2025
ASGPR-binding compounds for the degradation of extracellular proteins2025
ASGPR-binding compounds for the degradation of extracellular proteins2025
NLRP3 modulators2024
ASGPR-binding compounds for the degradation of extracellular proteins2024
Potent ASGPR-binding compounds for the degradation of immunoglobulins and other 2024
Compounds and compositions for treating conditions associated with NLRP activity2024
ASGPR-binding compounds for the degradation of extracellular proteins2024
NLRP3 modulators2024
NLRP3 modulators2023